Hexa Reports Market Research Reports and Insightful Company Profiles Contact Dermatitis Market Size, Share, Treatment, Symptoms, Analysis, Segmented Overview and Outlook, Pipeline Review, H1 2016 Global Markets Direct's, 'Contact Dermatitis - Pipeline Review, H1 2016', provides an overview of the Contact Dermatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Contact Dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. Browse Detail Report With TOC @ http://www.hexareports.com/report/contact-dermatitis-pipelinereview-h1-2016/details Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Hexa Reports Market Research Reports and Insightful Company Profiles The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Contact Dermatitis - The report reviews pipeline therapeutics for Contact Dermatitis by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Contact Dermatitis therapeutics and enlists all their major and minor projects - The report assesses Contact Dermatitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Contact Dermatitis Reasons To Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Contact Dermatitis - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Contact Dermatitis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Hexa Reports Market Research Reports and Insightful Company Profiles - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Request A Sample copy of This Report @ http://www.hexareports.com/sample/119068 Table of Contents Table of Content 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Contact Dermatitis Overview 7 Therapeutics Development 8 Pipeline Products for Contact Dermatitis - Overview 8 Contact Dermatitis - Therapeutics under Development by Companies 9 Contact Dermatitis - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Contact Dermatitis - Products under Development by Companies 13 Contact Dermatitis - Companies Involved in Therapeutics Development 14 Aldeyra Therapeutics, Inc. 14 Anacor Pharmaceuticals, Inc. 15 AskAt Inc. 16 Brickell Biotech, Inc. 17 Dr. August Wolff GmbH & Co. KG Arzneimittle 18 Hapten Sciences, Inc. 19 ILiAD Biotechnologies, LLC 20 LegoChem Biosciences, Inc 21 Marinomed Biotechnologie GmbH 22 Novartis AG 23 Signum Dermalogix, Inc 24 Sucampo Pharmaceuticals, Inc. 25 Contact Dermatitis - Therapeutics Assessment 26 Assessment by Monotherapy Products 26 Assessment by Target 27 Assessment by Mechanism of Action 29 Assessment by Route of Administration 31 Assessment by Molecule Type 33 Drug Profiles 35 AAT-008 - Drug Profile 35 Hexa Reports Market Research Reports and Insightful Company Profiles Product Description 35 Mechanism of Action 35 R&D Progress 35 AN-3485 - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 BBI-2000 - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 beta-escin - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 grapiprant - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Browse Full Report @ http://www.hexareports.com/report/contact-dermatitis-pipeline-review-h12016/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: [email protected] Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in
Global Markets Direct's, 'Contact Dermatitis - Pipeline Review, H1 2016', provides an overview of the Contact Dermatitis pipeline landscape.
© Copyright 2024 Paperzz
